TY  - GEN
N2  - For decades, the debate on human gene-editing has identified and agreed upon certain limits that draw the line between ethical and unethical territory: for example, applications for diseases are accepted, but not for enhancements. However, society keeps pushing the limits, as seen with the advent of CRISPR technology and the birth of the first genetically modified babies in China. John H. Evans rethinks how we discuss and debate these collective limits, which have long been characterized as a slippery slope. He examines past, present, and future arguments, and argues which limits can hold and which cannot, before we reach the dystopian bottom.
AB  - For decades, the debate on human gene-editing has identified and agreed upon certain limits that draw the line between ethical and unethical territory: for example, applications for diseases are accepted, but not for enhancements. However, society keeps pushing the limits, as seen with the advent of CRISPR technology and the birth of the first genetically modified babies in China. John H. Evans rethinks how we discuss and debate these collective limits, which have long been characterized as a slippery slope. He examines past, present, and future arguments, and argues which limits can hold and which cannot, before we reach the dystopian bottom.
T1  - The human gene editing debate /
AU  - Evans, John Hyde,
CN  - Oxford Scholarship Online
CN  - QH438.7
N1  - Previously issued in print: 2020.
ID  - 946779
KW  - Gene editing
KW  - Human genetics.
SN  - 9780197519592 
TI  - The human gene editing debate /
LK  - https://univsouthin.idm.oclc.org/login?url=https://dx.doi.org/10.1093/oso/9780197519561.001.0001
UR  - https://univsouthin.idm.oclc.org/login?url=https://dx.doi.org/10.1093/oso/9780197519561.001.0001
ER  -